Little information is available about the usefulness of concurrent chemoradiotherapy for locally advanced thymic carcinoma due to a rare anterior mediastinal tumor. We experienced a case of locally advanced thymic carcinoma that responded well to concurrent thoracic radiotherapy combined with cisplatin plus vinorelbine chemotherapy. The patient showed remarkable tumor regression and has remained disease free for over 4 years following combined therapy. Concurrent chemoradiotherapy seems to be effective for locally advanced thymic carcinoma, and cisplatin plus vinorelbine could be an alternative chemotherapy regimen in combination with thoracic radiotherapy in patients with thymic carcinoma
Chemotherapy is active against malignant thymomas, improving the resectability rate and the outcome ...
Thirty consecutive patients with stage IIIB-IV non small cell lung cancer were treated with a combin...
Introduction:Thymic carcinoma is a rare epithelial neoplasm that tends to be aggressive and metastas...
Thymic carcinoma is a rare epithelial malignancy differentiated from thymoma by the presence of cyto...
IntroductionConcurrent chemoradiotherapy with full doses of cisplatin-based chemotherapy is standard...
Background: Concurrent chemoradiotherapy is the current standard treatment for inoperable stage III ...
Objectives: Thymic carcinoma is a rare neoplasm more invasive and with a poorer prognosis than ordin...
The role of concurrent chemoradiotherapy (CRT) in patients with non-small-cell lung cancer (NSCLC) u...
Thymic carcinoma is a rare but aggressive neoplasm. Although there is no clearly optimal first- or s...
This is a non-final version of an article published in final form in JOURNAL OF THORACIC ONCOLOGY. 6...
Copyright © 2013 Hisao Higo et al. This is an open access article distributed under the Creative Com...
Background:Thymoma and thymic carcinomas are rare malignancies. Most thymomas and about one-third of...
Aim: Despite recent advances, outcomes for patients with stage III non–small cell lung cancer (NSCLC...
Background and objective Surgical resection remains the mainstay of treatment for patients with earl...
From 1990 to 1997, 16 consecutive patients with stage III and IVa invasive thymoma were treated in a...
Chemotherapy is active against malignant thymomas, improving the resectability rate and the outcome ...
Thirty consecutive patients with stage IIIB-IV non small cell lung cancer were treated with a combin...
Introduction:Thymic carcinoma is a rare epithelial neoplasm that tends to be aggressive and metastas...
Thymic carcinoma is a rare epithelial malignancy differentiated from thymoma by the presence of cyto...
IntroductionConcurrent chemoradiotherapy with full doses of cisplatin-based chemotherapy is standard...
Background: Concurrent chemoradiotherapy is the current standard treatment for inoperable stage III ...
Objectives: Thymic carcinoma is a rare neoplasm more invasive and with a poorer prognosis than ordin...
The role of concurrent chemoradiotherapy (CRT) in patients with non-small-cell lung cancer (NSCLC) u...
Thymic carcinoma is a rare but aggressive neoplasm. Although there is no clearly optimal first- or s...
This is a non-final version of an article published in final form in JOURNAL OF THORACIC ONCOLOGY. 6...
Copyright © 2013 Hisao Higo et al. This is an open access article distributed under the Creative Com...
Background:Thymoma and thymic carcinomas are rare malignancies. Most thymomas and about one-third of...
Aim: Despite recent advances, outcomes for patients with stage III non–small cell lung cancer (NSCLC...
Background and objective Surgical resection remains the mainstay of treatment for patients with earl...
From 1990 to 1997, 16 consecutive patients with stage III and IVa invasive thymoma were treated in a...
Chemotherapy is active against malignant thymomas, improving the resectability rate and the outcome ...
Thirty consecutive patients with stage IIIB-IV non small cell lung cancer were treated with a combin...
Introduction:Thymic carcinoma is a rare epithelial neoplasm that tends to be aggressive and metastas...